Liquidia Technologies
Founded Year
2004Stage
IPO | IPOTotal Raised
$99.3MDate of IPO
7/26/2018Market Cap
0.43BStock Price
6.39About Liquidia Technologies
Liquidia Technologies (NASDAQ: LQDA) is a late-stage clinical biopharmaceutical company that is focused on improving the performance of medicines by precisely engineering drug particles. Liquidia's proprietary PRINT technology is designed to optimize the safety, efficacy or route of administration of a wide range of therapies by engineering uniform drug particles in a wide variety of compositions, sizes and shapes.
Missing: Liquidia Technologies's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Liquidia Technologies's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Liquidia Technologies
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Liquidia Technologies is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
15,535 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Liquidia Technologies Patents
Liquidia Technologies has filed 32 patents.
The 3 most popular patent topics include:
- Dosage forms
- Drug delivery devices
- G protein coupled receptors
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/5/2017 | 1/26/2021 | Dosage forms, Drug delivery devices, Hypertension, Routes of administration, G protein coupled receptors | Grant |
Application Date | 5/5/2017 |
|---|---|
Grant Date | 1/26/2021 |
Title | |
Related Topics | Dosage forms, Drug delivery devices, Hypertension, Routes of administration, G protein coupled receptors |
Status | Grant |
Latest Liquidia Technologies News
Jan 10, 2023
The pharmaceutical company has landed financing to support the potential launch of a drug at the center of an ongoing patent dispute with United Therapeutics.
Liquidia Technologies Frequently Asked Questions (FAQ)
When was Liquidia Technologies founded?
Liquidia Technologies was founded in 2004.
Where is Liquidia Technologies's headquarters?
Liquidia Technologies's headquarters is located at 419 Davis Drive, Morrisville.
What is Liquidia Technologies's latest funding round?
Liquidia Technologies's latest funding round is IPO.
How much did Liquidia Technologies raise?
Liquidia Technologies raised a total of $99.3M.
Who are the investors of Liquidia Technologies?
Investors of Liquidia Technologies include New Enterprise Associates, Canaan Partners, Morningside Ventures, Bill & Melinda Gates Foundation, Firelake Capital and 7 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.